IL-NIQ
NIQ, the global leader in consumer intelligence, is pleased to announce the NIQ Connect platform capabilities have now expanded to use Snowflake Secure Data Sharing. This capability marks a significant milestone for NIQ's Connect platform, empowering customers in 84 global markets with enhanced data-sharing capabilities and seamless real-time data access. As a result, this can eliminate processing and loading wait times, delivering unparalleled efficiency and agility in a complex consumer landscape.
“By extending their ability to effortlessly access global, omnichannel data, we can empower clients to uncover new pathways to growth even within a very complex consumer landscape,” said Troy Treangen, Chief Product Officer at NIQ. “Innovation is our compass, and our commitment to reengineering the Connect platform has charted a new course. Our strategic investments have allowed us to unlock the power of modern data sharing capabilities, guiding our clients towards a brighter, data-driven future."
NIQ Connect is a crucial asset for enterprises, enabling them to harness their data across all facets of their organization. With integrated data assets, businesses can readily identify emerging trends, pinpoint performance gaps, and respond swiftly to growth opportunities. This global collaboration is poised to unveil novel insights, leading to a deeper understanding of customers' behavior and preferences.
Additional highlights of the NIQ’s Connect platform integration with Snowflake’s Retail Data Cloud include:
- Seamless Data Integration: Companies will benefit from the seamless integration of NIQ's rich consumer and market data into Snowflake’s environment. This integration simplifies access to vast data sources, and drives significant speed improvements for our clients when accessing data.
- Secure Data Sharing: Availability through Snowflake facilitates near real-time data sharing, enabling businesses to access and query NIQ's data instantaneously. This dynamic exchange of information empowers organizations to stay ahead in today's fast-paced business landscape.
- Scalability and Flexibility: NIQ’s Connect platform with Snowflake Secure Data Sharing is designed to scale effortlessly with the growing data needs of businesses. Whether a company is a startup or a Fortune 500 enterprise, this provides the flexibility to adapt and grow in a rapidly changing environment.
- Enhanced AI and Machine Learning Capabilities: Businesses can leverage advanced analytics and machine learning within Snowflake's platform to derive actionable insights from NIQ's data. This synergy fosters innovation, enabling companies to make data-driven decisions with precision.
- Data Security and Compliance: Both NIQ and Snowflake prioritize data security and compliance. The joint solution ensures that sensitive data is protected providing peace of mind to businesses and their customers while enabling them to meet evolving regulatory requirements.
“NIQ is committed to helping companies become more agile at a time when being able to move quickly based on accurate data is paramount,” Treangen added. “This innovative data-sharing approach will provide Connect customers a competitive advantage today and be better prepared for the future. We are modernizing every level of our Connect platform, and we are excited about the enhancements to help our clients thrive.”
“As an incumbent leader in retail and consumer insights, NIQ has been a staple in the retail industry for delivering data that give a competitive edge to retailers and consumer product companies,” said Rosemary DeAragon, Global Head of Retail and Consumer Goods at Snowflake. “We are so excited to bring together the full power of the Snowflake Retail Data Cloud and the NIQ Connect platform, allowing global frictionless access to critical data through Snowflake data sharing.”
NIQ is dedicated to fostering innovation and enabling organizations to thrive in a data-driven world. The collaboration between NIQ and Snowflake represents a transformative step in the world of data sharing and will shape the future of data analytics. As organizations increasingly recognize the value of data in their operations, allowing them to exchange insights seamlessly and efficiently will empower them to unlock new opportunities and navigate the data landscape with ease.
For more information about this NIQ Connect and its benefits, please visit https://nielseniq.com/global/en/solutions/nielseniq-connect/.
About NIQ
NIQ is the world’s leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. In 2023, NIQ combined with GfK, bringing together the two industry leaders with unparalleled global reach. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full ViewTM.
NIQ, is an Advent International portfolio company with operations in 100+ markets, covering more than 90% of the world’s population. For more information, visit NIQ.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230919644465/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TreeFrog Therapeutics Announces Changes to Executive Committee With the Arrival of Mark Rothera as Chief Executive Officer & Board Member to Spearhead Next Phase of Growth16.12.2025 09:05:00 CET | Press release
TreeFrog Therapeutics, a French biotech focused on bringing regenerative medicine to millions through their proprietary cell technology, C-Stem™ is delighted to announce the appointment of skilled biotech leader, Mark Rothera, as Chief Executive Officer and Board member. He succeeds Frédéric Desdouits, who is stepping down after five years in the role. In the new leadership configuration, co-founders Kévin Alessandri and Maxime Feyeux will transition from daily operations to focus on their roles on the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215145193/en/ Mark Rothera, CEO TreeFrog Therapeutics Elsy Boglioli, Chair of the Board of TreeFrog Therapeutics, commented “On behalf of the Board, we are delighted to welcome Mark to TreeFrog. His 30+ years of biopharma leadership, including most recently, three biotech CEO roles in gene therapy and biologics, will be invaluable as we advance our Parkinson’s and liver
RoslinCT and Ayrmid Ltd. Announce Expansion of Strategic Partnership to Manufacture Omisirge® (omidubicel-onlv) for Second FDA-Approved Indication in Severe Aplastic Anemia (SAA)16.12.2025 09:00:00 CET | Press release
RoslinCT is performing technology transfer and will support commercial manufacture of Omisirge® for an additional indication following successful clinical trialsOmisirge® now FDA-approved for an expanded patient population in hematologyRoslinCT continues to support and advance multiple cell therapy projects at its Hopkinton, MA facility Ayrmid Ltd., the parent company of Gamida Cell Inc., a pioneering cell therapy company transforming cells into powerful therapeutics, and RoslinCT, a global leader in cell and gene therapy contract development and manufacturing, today announced the expansion of their strategic partnership to include the execution of a commercial supply agreement to support production of Omisirge® (omidubicel-onlv). Following positive clinical trial results, Omisirge® has received FDA approval for a second indication, broadening its use in the treatment of hematology patients. Under the commercial supply agreement, RoslinCT will complete technology transfer and support c
Echoworx Secures FSQS-Netherlands Certification, Strengthening Trust in Financial Data Protection16.12.2025 07:00:00 CET | Press release
Leading encryption provider deepens commitment to European financial sector with rigorous new supplier qualification, building on existing UK & Ireland certification. Echoworx, a global leader in email and data encryption, proudly announces it has achieved Financial Services Qualification System (FSQS) registered supplier status for the Netherlands. This certification powerfully demonstrates Echoworx’s commitment to the highest standards of security and compliance. This achievement expands on the company’s existing FSQS certification for the UK and Ireland, secured in 2020. By successfully completing the rigorous qualification for the Netherlands, Echoworx reinforces its alignment with the stringent demands of the European financial market. The FSQS system, managed by Hellios, provides a single, reliable standard for vetting third-party suppliers, streamlining procurement for major banks and financial institutions. Think of FSQS as a high-security passport for technology partners. It p
Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace16.12.2025 03:00:00 CET | Press release
Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary all-electric melting technology with renewable energy, CO2 emissions from glass tubing production can be reduced by up to 90%*1 compared with conventional fossil-fuel combustion furnaces. This positions NEG as a major supplier capable of delivering both high-performance borosilicate glass and a significantly lower carbon footprint, directly addressing global sustainability demands from pharmaceutical companies and regulators. NEG is a leading global supplier of arsenic-free, environmentally friendly borosilicate glass tubing f
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform16.12.2025 02:00:00 CET | Press release
Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine-On’s IND submission. The IND was cleared by the U.S. FDA in Q1 2025. Furthermore, Esco Aster is providing technical services for exploratory exosome loading feasibility studies per Shine-On’s instruction. Shine-On Biomedical is an emerging innovator in exosome-based drug delivery. ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G targeted exosome platfo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom